The Biden Administration has announced another delay in implementing a ban on menthol cigarettes, a move first proposed by the Food and Drug Administration (FDA) in 2021. Health and Human Services Secretary Xavier Becerra stated that further discussions are required, indicating the process will extend beyond the anticipated timeline. This decision comes despite earlier promises to enact the ban by the end of last year, aiming to address the disproportionately high usage of menthol cigarettes among Black Americans and the associated health disparities.
Health organizations have expressed significant disappointment over the postponement. Nancy Brown, CEO of the American Heart Association, criticized the administration for not acting on the scientific evidence supporting the ban, thereby allowing the tobacco industry to continue marketing these addictive products. Similarly, Harold Wimmer, President and CEO of the American Lung Association, lamented the missed opportunity to combat tobacco-related death and disease.
The delay raises concerns about the impact of the decision on Black voters ahead of the 2024 presidential election. Critics, including Carol McGruder of the African American Tobacco Control Leadership Council, accused the administration of yielding to tobacco industry pressures at the expense of public health, particularly within the Black community. The ongoing delays have sparked a broader debate on the administration’s commitment to addressing health inequities and the influence of corporate lobbying in public health policies.
Pic Courtesy: google/ images are subject to copyright
